-
Section Testdetails Section (2.16.840.1.113883.2.6.60.13.10.18)
-
Entry Clinical Genomic Statement (2.16.840.1.113883.10.20.20.2)
-
Entry Indication Observation (2.16.840.1.113883.10.20.20.3.3)
-
Entry Interpretive Phenotype (2.16.840.1.113883.10.20.20.2.5)
-
Entry Genomic Source Class (2.16.840.1.113883.10.20.20.3.2)
-
Entry Genomic Associated Observation (2.16.840.1.113883.10.20.20.4)
-
Section Indications Section (2.16.840.1.113883.10.20.20.1.11)
-
Entry Indication Observation (2.16.840.1.113883.10.20.20.3.3)
-
Entry Genetic Disease Assessed Indication Observation (2.16.840.1.113883.10.20.20.3.3.1)
-
Entry Medication Assessed Indication Observation (2.16.840.1.113883.10.20.20.3.3.2)
-
Section Test Performed Section (2.16.840.1.113883.10.20.20.1.10)
-
Entry Test Performed Observation (2.16.840.1.113883.10.20.20.3.4)
-
Section Findings Section (2.16.840.1.113883.10.20.20.1.12)
-
Section Interpretation Section (2.16.840.1.113883.10.20.20.1.13)
-
Entry Interpretive Phenotype (2.16.840.1.113883.10.20.20.2.5)
-
Section Test Information Section (2.16.840.1.113883.10.20.20.1.9)
-
Section Background Section (2.16.840.1.113883.10.20.20.1.9.1)
-
Section Methodology Section (2.16.840.1.113883.10.20.20.1.9.2)
-
Section References Section (2.16.840.1.113883.10.20.20.1.9.3)
-
Section Specimen Section (2.16.840.1.113883.10.20.20.1.7)
-
Entry Genomic Source Class (2.16.840.1.113883.10.20.20.3.2)
|